Elliott Kieff - Concepedia

Author

Elliott Kieff

Harvard University

Also Known As

E D Kieff, E Kieff, E. D. Kieff, E. Kieff, Elliott D. Kieff, Elliott Kieff, Elliott D. Kieff

318

Publications

39.8K

Citations

110

H-Index

144

Concepts

All Affiliations

Harvard University Brigham and Women's Hospital University of Chicago

About

Elliott Kieff is an author at Harvard University specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	90	195	28.2K
2	Natural Sciences	39	48	4.8K
3	Allergy	7	7	344
4	Engineering	2	2	130
5	Health Sciences	1	1	15

Elliott Kieff

270

Publications

37.9K

Citations

108

H-Index

Page 1

	Year	Citations
Epstein-Barr virus and its replication Elliott Kieff Medical Entomology and Zoology Viral ReplicationViral PersistenceEpstein-barr VirusPathogenesisImmunology	1996	1.6K
An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells David Wang, David Liebowitz, Elliott Kieff Cell Molecular VirologyCell SignalingRodent CellsImmunologyViral Pathogenesis	1985	1.3K
Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell death S. A. Henderson, Martin Rowe, C D Gregory, Cell ApoptosisImmunologyB CellsCell DeathPathology	1991	1.2K
Characterization of Herpes Simplex Virus Strains Differing in their Effects on Social Behaviour of Infected Cells P. M. Ejercito, Elliott Kieff, Bernard Roizman Journal of General Virology Viral DiagnosticsViral PathogenesisImmunologyViral DynamicSummary Established	1968	875
Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Kenneth M. Kaye, Kenneth M. Izumi, Elliott Kieff Proceedings of the National Academy of Sciences Viral ReplicationLymphocyte DevelopmentImmunologyViral PathogenesisPathology	1993	770
Expression of Epstein–Barr Virus Transformation–Associated Genes in Tissues of Patients with EBV Lymphoproliferative Disease Lawrence S. Young, Caroline Alfieri, Helen Evans, New England Journal of Medicine ImmunologyPathologyImmunotherapyCancer-associated VirusEpstein-barr Virus	1989	767
Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23 F Wang, C D Gregory, Clare E. Sample, Journal of Virology Adaptive Immune SystemImmunologyPathologyImmunologic MechanismB Lymphocytes	1990	575
Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation Joan B. Mannick, Koichiro Asano, Kenneth M. Izumi, Cell Reactive Nitrogen SpecieNitric OxideApoptosisImmunologyImmune Regulation	1994	507
Epstein-barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis Jerome E. Tanner, Janis J. Weis, Douglas T. Fearon, Cell ImmunologyAntiviral ResponsePathologyVirologyImmunologic Mechanism	1987	495
Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes Jeffery T. Sample, Lawrence S. Young, Brian A.B. Martin, Journal of Virology Viral EvolutionCancer-associated VirusMolecular VirologyEbna-3c GenesEpstein-barr Virus	1990	493

Page 1